Monday, March 3, 2014

Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.

Citalopram appears to be effective in reducing agitation in Alzheimer's Disease. However, side-effects were significant, with patients on citalopram experiencing worsened cognition and QT interval prolongation.
Read More